Senna leaf

DB15889ApprovedInvestigationalOrganism Based Therapies

Senna leaf is a stimulant laxative indicated in the treatment of occasional constipation. A medication used to treat constipation.

Mechanism
Curator reviewed
First approval
Canada, 1997
Also known as
Alexandrian senna leaf · Cassia angustifolia leaf · Cassia angustifolia leaf extract · Cassia senna leaf · Cassia senna leaf extract
Code names
B2056

Resolves to

Compound
UNIIAK7JF626KX
Clinical / RWD
RxNorm485853

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
397Drug interactionsStructured to mechanism, not free text
Sign in
25Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
55Marketed productsAcross 6 countries and 33 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Senna leaf, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In